期刊
ARCHIVES OF NEUROLOGY
卷 65, 期 4, 页码 447-451出版社
AMER MEDICAL ASSOC
DOI: 10.1001/archneur.65.4.nnr70007
关键词
-
The identification of the genes and proteins involved in many neurodegenerative diseases(1) offers the exciting possibility of modifying those disease-linked proteins to develop novel, targeted therapies for diseases such as amyotrophic lateral sclerosis (ALS) or Huntington disease. In many of these diseases, the simplest modification-decreasing the amount of the offending protein-may represent a potent therapy. This realization, coupled with great strides in the techniques for decreasing specific proteins, has set the stage for moving these new therapies from animal models to clinical trials in the near future.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据